1	Human	human	_	_	_	_	_	_	_
2	T	t	_	_	_	_	_	_	_
3	lymphotropic	lymphotropic	_	_	_	_	_	_	_
4	virus-I	virus-i	_	_	_	_	_	_	_
5	infection	infection	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	human	human	_	_	_	_	_	_	_
8	T	t	_	_	_	_	_	_	_
9	lymphocytes	lymphocyte	_	_	_	_	_	_	_
10	induces	induce	_	_	_	_	_	_	_
11	expression	expression	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	beta-galactoside-binding	beta-galactoside-binding	_	_	_	_	_	_	_
15	lectin	lectin	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	galectin-3	galectin-3	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Animal	Animal	_	_	_	_	_	_	_
2	lectins	lectin	_	_	_	_	_	_	_
3	play	play	_	_	_	_	_	_	_
4	important	important	_	_	_	_	_	_	_
5	roles	role	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	variety	variety	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	biological	biological	_	_	_	_	_	_	_
11	processes	process	_	_	_	_	_	_	_
12	via	via	_	_	_	_	_	_	_
13	their	their	_	_	_	_	_	_	_
14	recognition	recognition	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	glycoconjugates	glycoconjugate	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Galectin-3	galectin-3	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	beta-galactoside-binding	beta-galactoside-binding	_	_	_	_	_	_	_
5	lectin	lectin	_	_	_	_	_	_	_
6	previously	previously	_	_	_	_	_	_	_
7	designated	designate	_	_	_	_	_	_	_
8	as	as	_	_	_	_	_	_	_
9	epsilon	epsilon	_	_	_	_	_	_	_
10	BP	BP	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	IgE-binding	ige-binding	_	_	_	_	_	_	_
13	protein	protein	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	CBP35	CBP35	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	Mac-2	Mac-2	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	L-29	L-29	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	L-34	l-34	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	its	its	_	_	_	_	_	_	_
27	expression	expression	_	_	_	_	_	_	_
28	has	have	_	_	_	_	_	_	_
29	been	be	_	_	_	_	_	_	_
30	associated	associate	_	_	_	_	_	_	_
31	with	with	_	_	_	_	_	_	_
32	various	various	_	_	_	_	_	_	_
33	physiological	physiological	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	pathological	pathological	_	_	_	_	_	_	_
36	processes	process	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	including	include	_	_	_	_	_	_	_
39	cell	cell	_	_	_	_	_	_	_
40	growth	growth	_	_	_	_	_	_	_
41	,	,	_	_	_	_	_	_	_
42	tumor	tumor	_	_	_	_	_	_	_
43	transformation	transformation	_	_	_	_	_	_	_
44	,	,	_	_	_	_	_	_	_
45	and	and	_	_	_	_	_	_	_
46	metastasis	metastasis	_	_	_	_	_	_	_
47	.	.	_	_	_	_	_	_	_

1	Galectin-3	galectin-3	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	widely	widely	_	_	_	_	_	_	_
4	distributed	distribute	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	various	various	_	_	_	_	_	_	_
7	tissues	tissue	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	cell	cell	_	_	_	_	_	_	_
10	types	type	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	expressed	express	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	many	many	_	_	_	_	_	_	_
16	leukocytes	leukocyte	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	notable	notable	_	_	_	_	_	_	_
21	exception	exception	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	B	B	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	T	t	_	_	_	_	_	_	_
26	lymphocytes	lymphocyte	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	now	now	_	_	_	_	_	_	_
3	report	report	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	galectin-3	galectin-3	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	abundantly	abundantly	_	_	_	_	_	_	_
8	expressed	express	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	number	number	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	human	human	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	lymphotropic	lymphotropic	_	_	_	_	_	_	_
16	virus	virus	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	HTLV)-I-infected	htlv)-i-infected	_	_	_	_	_	_	_
19	human	human	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	lines	line	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	including	include	_	_	_	_	_	_	_
25	F6T	F6T	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	HUT	HUT	_	_	_	_	_	_	_
28	102	102	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	K3T	K3T	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	MT-2	MT-2	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	SLB-I	SLB-I	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	but	but	_	_	_	_	_	_	_
38	is	be	_	_	_	_	_	_	_
39	not	not	_	_	_	_	_	_	_
40	expressed	express	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	non-HTLV-I-infected	non-htlv-i-infected	_	_	_	_	_	_	_
43	T	t	_	_	_	_	_	_	_
44	cell	cell	_	_	_	_	_	_	_
45	lines	line	_	_	_	_	_	_	_
46	such	such	_	_	_	_	_	_	_
47	as	as	_	_	_	_	_	_	_
48	Jurkat	Jurkat	_	_	_	_	_	_	_
49	,	,	_	_	_	_	_	_	_
50	CEM	CEM	_	_	_	_	_	_	_
51	,	,	_	_	_	_	_	_	_
52	and	and	_	_	_	_	_	_	_
53	MOLT-4	molt-4	_	_	_	_	_	_	_
54	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	galectin-3	galectin-3	_	_	_	_	_	_	_
6	level	level	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	markedly	markedly	_	_	_	_	_	_	_
9	increased	increase	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	human	human	_	_	_	_	_	_	_
12	thymocytes	thymocyte	_	_	_	_	_	_	_
13	after	after	_	_	_	_	_	_	_
14	infection	infection	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	HTLV-I	HTLV-I	_	_	_	_	_	_	_
17	as	as	_	_	_	_	_	_	_
18	compared	compare	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	uninfected	uninfected	_	_	_	_	_	_	_
21	thymocytes	thymocyte	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	up-regulation	up-regulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	galectin-3	galectin-3	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	appeared	appear	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	correlate	correlate	_	_	_	_	_	_	_
9	well	well	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	HTLV-I	HTLV-I	_	_	_	_	_	_	_
12	gene	gene	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	as	as	_	_	_	_	_	_	_
16	undetectable	undetectable	_	_	_	_	_	_	_
17	or	or	_	_	_	_	_	_	_
18	very	very	_	_	_	_	_	_	_
19	low	low	_	_	_	_	_	_	_
20	levels	level	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	galectin-3	galectin-3	_	_	_	_	_	_	_
23	were	be	_	_	_	_	_	_	_
24	found	find	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	S1T	S1T	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	ATL-1K	ATL-1K	_	_	_	_	_	_	_
30	cell	cell	_	_	_	_	_	_	_
31	lines	line	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	which	which	_	_	_	_	_	_	_
34	are	be	_	_	_	_	_	_	_
35	nonproductively	nonproductively	_	_	_	_	_	_	_
36	infected	infect	_	_	_	_	_	_	_
37	with	with	_	_	_	_	_	_	_
38	HTLV-I	HTLV-I	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	co-transfection	co-transfection	_	_	_	_	_	_	_
3	experiments	experiment	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	galectin-3	galectin-3	_	_	_	_	_	_	_
7	promoter	promoter	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	significantly	significantly	_	_	_	_	_	_	_
10	up-regulated	up-regulate	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	vectors	vector	_	_	_	_	_	_	_
14	encoding	encode	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	40-kd	40-kd	_	_	_	_	_	_	_
17	Tax	tax	_	_	_	_	_	_	_
18	protein	protein	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	potent	potent	_	_	_	_	_	_	_
22	transactivator	transactivator	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	HTLV-I	HTLV-I	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Analysis	Analysis	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	various	various	_	_	_	_	_	_	_
4	Tax	Tax	_	_	_	_	_	_	_
5	mutants	mutant	_	_	_	_	_	_	_
6	suggested	suggest	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	galectin-3	galectin-3	_	_	_	_	_	_	_
9	promoter	promoter	_	_	_	_	_	_	_
10	induction	induction	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	dependent	dependent	_	_	_	_	_	_	_
13	on	on	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	cyclic-AMP-responsive	cyclic-amp-responsive	_	_	_	_	_	_	_
18	element	element	_	_	_	_	_	_	_
19	binding	binding	_	_	_	_	_	_	_
20	protein/activation	protein/activation	_	_	_	_	_	_	_
21	transcription	transcription	_	_	_	_	_	_	_
22	factor	factor	_	_	_	_	_	_	_
23	family	family	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	transcription	transcription	_	_	_	_	_	_	_
26	factors	factor	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	to	to	_	_	_	_	_	_	_
30	a	a	_	_	_	_	_	_	_
31	lesser	less	_	_	_	_	_	_	_
32	extent	extent	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	nuclear	nuclear	_	_	_	_	_	_	_
35	factor-kappa	factor-kappa	_	_	_	_	_	_	_
36	B/Rel	B/Rel	_	_	_	_	_	_	_
37	induction	induction	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	Transfection	transfection	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	human	human	_	_	_	_	_	_	_
4	promonocytic	promonocytic	_	_	_	_	_	_	_
5	U-937	u-937	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	an	an	_	_	_	_	_	_	_
9	HTLV-I	HTLV-I	_	_	_	_	_	_	_
10	Tax	Tax	_	_	_	_	_	_	_
11	expression	expression	_	_	_	_	_	_	_
12	vector	vector	_	_	_	_	_	_	_
13	induced	induce	_	_	_	_	_	_	_
14	galectin-3	galectin-3	_	_	_	_	_	_	_
15	expression	expression	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	this	this	_	_	_	_	_	_	_
18	cell	cell	_	_	_	_	_	_	_
19	line	line	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Functionally	functionally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	galectin-3	galectin-3	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	shown	show	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	activate	activate	_	_	_	_	_	_	_
8	interleukin-2	interleukin-2	_	_	_	_	_	_	_
9	production	production	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	Jurkat	Jurkat	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Together	together	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	findings	finding	_	_	_	_	_	_	_
5	raise	raise	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	possibility	possibility	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	HTLV-I	HTLV-I	_	_	_	_	_	_	_
10	Tax	Tax	_	_	_	_	_	_	_
11	production	production	_	_	_	_	_	_	_
12	induces	induce	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	transcription	transcription	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	subsequent	subsequent	_	_	_	_	_	_	_
17	synthesis	synthesis	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	secretion	secretion	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	galectin-3	galectin-3	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	which	which	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	turn	turn	_	_	_	_	_	_	_
26	may	may	_	_	_	_	_	_	_
27	further	further	_	_	_	_	_	_	_
28	activate	activate	_	_	_	_	_	_	_
29	these	these	_	_	_	_	_	_	_
30	T	t	_	_	_	_	_	_	_
31	cells	cell	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	contribute	contribute	_	_	_	_	_	_	_
34	to	to	_	_	_	_	_	_	_
35	the	the	_	_	_	_	_	_	_
36	altered	alter	_	_	_	_	_	_	_
37	properties	property	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	cell	cell	_	_	_	_	_	_	_
40	growth	growth	_	_	_	_	_	_	_
41	found	find	_	_	_	_	_	_	_
42	in	in	_	_	_	_	_	_	_
43	adult	adult	_	_	_	_	_	_	_
44	T	t	_	_	_	_	_	_	_
45	cell	cell	_	_	_	_	_	_	_
46	leukemia	leukemia	_	_	_	_	_	_	_
47	induced	induce	_	_	_	_	_	_	_
48	by	by	_	_	_	_	_	_	_
49	HTLV-I	HTLV-I	_	_	_	_	_	_	_
50	.	.	_	_	_	_	_	_	_

